Evidence map›Paper›PMID 28848493›Full record

ArticleFrontiers in neurology2017

Progressive Encephalomyelitis with Rigidity and Myoclonus Associated With Anti-GlyR Antibodies and Hodgkin's Lymphoma: A Case Report.

Linda Borellini, Silvia Lanfranconi, Sara Bonato, Ilaria Trezzi, Giulia Franco, Lorella Torretta, Nereo Bresolin, Alessio Barnaba Di Fonzo

Open access · goldAbstract readCase Reports
In one paragraph

Article in Frontiers in neurology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Linda BorelliniNeurology Department, IRCCS Fondazione Cà Granda Ospedale Maggiore Policlinico, Milan, Italy.
Silvia LanfranconiNeurology Department, IRCCS Fondazione Cà Granda Ospedale Maggiore Policlinico, Milan, Italy.
Sara BonatoNeurology Department, IRCCS Fondazione Cà Granda Ospedale Maggiore Policlinico, Milan, Italy.
Ilaria TrezziNeurology Department, IRCCS Fondazione Cà Granda Ospedale Maggiore Policlinico, Milan, Italy.
Giulia FrancoNeurology Department, IRCCS Fondazione Cà Granda Ospedale Maggiore Policlinico, Milan, Italy.
Lorella TorrettaAferesi Terapeutica, Centro Trasfusionale, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy.
Nereo BresolinNeurology Department, IRCCS Fondazione Cà Granda Ospedale Maggiore Policlinico, Milan, Italy.
Alessio Barnaba Di FonzoNeurology Department, IRCCS Fondazione Cà Granda Ospedale Maggiore Policlinico, Milan, Italy.
Ferrari (Italy) · ITFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico · ITUniversity of Milan · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionA 60-year-old man presented with a 6-month history of low back pain and progressive rigidity of the trunk and lower limbs, followed by pruritus, dysphonia, hyperhydrosis, and urinary retention. Brain and spinal imaging were normal. EMG showed involuntary motor unit hyperactivity. Onconeural, antiglutamic acid decarboxylase (anti-GAD), voltage-gated potassium channel, and dipeptidyl peptidase-like protein 6 (DPPX) autoantibodies were negative. CSF was negative. Symptoms were partially responsive to baclofen, gabapentin, and clonazepam, but he eventually developed severe dysphagia. Antiglycine receptor (anti-GlyR) antibodies turned out positive on both serum and CSF. A plasmapheresis cycle was completed with good clinical response. A PET scan highlighted an isolated metabolically active axillary lymphnode that turned out to be a classic type Hodgkin lymphoma (HL), in the absence of bone marrow infiltration nor B symptoms. Polychemotherapy with ABVD protocol was completed with good clinical response and at 1-year follow-up the neurological examination is normal.

backgroundProgressive encephalomyelitis with rigidity and myoclonus (PERM) is a rare and severe neurological syndrome characterized by muscular rigidity and spasms as well as brain stem and autonomic dysfunction. It can be associated with anti-GAD, GlyR, and DPPX antibodies. All of these autoantibodies may be variably associated with malignant tumors and their response to immunotherapy, as well as to tumor removal, is not easily predictable.

conclusionProgressive encephalomyelitis with rigidity and myoclonus has already been described in association with HL, but this is the first case report of a HL manifesting as anti-GlyR antibodies related PERM. Our report highlights the importance of malignancy screening in autoimmune syndromes of suspected paraneoplastic origin.

Indexed as

glycine receptor antibodiesHodgkin’s lymphomaparaneoplastic syndromesprogressive encephalomyelitis with rigidity and myoclonusstiff person syndrome

Identifiers

PMID28848493
PMCPMC5554358
OpenAlexW2743928003

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.